Medical device and MedTech insights, news, tips and more

Dexcom Wins FDA Nod for Real-time APIs, Allowing Third-party Developers Access to CGM Data

July 18, 2021


Dexcom’s Partner Web Application Programming Interfaces (APIs) were cleared by the FDA, allowing approved third-party developers to connect to the continuous glucose monitoring data of Dexcom users.

Developers can integrate CGM data with their applications, diabetes management systems or devices through the new APIs, according to Thursday’s announcement. Diabetes management companies like Teladoc Health’s Livongo for Diabetes and the smartwatch maker Garmin are in the testing and development phase. Dexcom contends that the APIs will help patients and healthcare providers as both treatment information and patient-specific CGM information will be in one place and allow for “in-the-moment diabetes management coaching and feedback.”

The clearance comes as multiple diabetes tech products are planned to be released this year. However, slower FDA reviews have delayed certain product launches, such as the much-anticipated Insulet Omnipod 5 insulin pump.

The FDA’s workload soared during the pandemic as coronavirus-related applications seeking review or emergency use authorization came in. The agency was also managing its typical, non-COVID-19-related submissions, which were delayed due to the prioritization of pandemic work.

While the agency has been stretched thin, work may return to normal soon, including the review of diabetes products or technologies.

Jeff Shuren, director of the FDA’s Centers for Devices and Radiological Health, said at the recent BofA Securities Healthcare conference that diabetes product applications are moving forward and the agency plans to return to normalcy beginning next year, according to a report from Seeking Alpha.

See Full Press Release at the Source: Dexcom wins FDA nod for real-time APIs, allowing third-party developers access to CGM data | MedTech Dive

Press Release by: Dexcom via MedTech Dive

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.